We may earn a commission from providers listed here, which can affect where they appear but never our ratings or reviews.
TopWeightLoss.us
Guide7 min read

GLP-1s After 65: Medicare's $50 GLP-1 Bridge Explained (2026)

Medicare's GLP-1 Bridge pilot sets a flat $50 monthly copay for Wegovy, the Zepbound KwikPen and Foundayo through December 2027. Who qualifies, and cash options.

Last updated October 8, 2026

Francheska Capistrano, Medical Content Reviewer

Francheska Capistrano, RMT, MPH

Clinically checked · Our review process

Short answerSince July 1, 2026, eligible Medicare beneficiaries can use the GLP-1 Bridge pilot to get the Wegovy pill and injection, the Zepbound KwikPen and Foundayo for a flat $50 monthly copay that stays the same as the dose rises, through December 31, 2027. Eligibility depends on clinical criteria plus an approval step through your Part D plan. Medicare never covers compounded GLP-1s. If you do not qualify, you can pay cash for brand-name drugs ($149-$349 a month for Foundayo, $1,149+ for injections) or for compounded versions ($49-$299).Prices checked on each provider’s website on October 16, 2026.

Key points

  • Since July 1, 2026, a CMS pilot called the Medicare GLP-1 Bridge has let eligible beneficiaries get covered obesity drugs for a flat $50 monthly copay: the Wegovy pill and injection, the Zepbound KwikPen and the Foundayo pill. The copay does not change as the dose increases.
  • The pilot is temporary and ends December 31, 2027; a longer-term program afterwards is possible but not guaranteed. Eligibility depends on clinical criteria and an approval step.
  • Medicare does not cover compounded GLP-1s. If you do not qualify for the Bridge, your cash options match everyone else's: brand-name direct from the manufacturer or through telehealth, or a compounded version at $49-$299 a month.
  • Older adults make up a large share of GLP-1 buyers, and muscle and bone concerns grow with age, which is a reason to use a clinician who monitors you rather than a form alone.

What is the Medicare GLP-1 Bridge program?

The Medicare GLP-1 Bridge is a pilot from the Centers for Medicare and Medicaid Services that lets eligible beneficiaries pay a flat $50 pharmacy copay for covered obesity drugs. It began on July 1, 2026 and runs through December 31, 2027.
  • Before 2026: Medicare Part D could cover a GLP-1 prescribed for diabetes, but not one prescribed for weight loss.
  • Under the Bridge: the $50 does not rise with the dose, which is unusual, because dose increases are where cash prices climb.
The name is literal: it is meant to bridge to a longer-term program that may or may not start in 2028.

Our 2 favorite GLP-1 providers

The two providers our editors recommend first, with the same checked prices and scores used in our full ranking.

Our Most Popular
1
embody logo

Exceptional

9.8out of 10

Semaglutide from $69/mo, delivered in 1-2 days

Refund if not approvedFree expedited shipping

Treatments offered

Compounded semaglutide injection (GLP-1) · Compounded tirzepatide injection (GLP-1 + GIP) · Online doctor review and prescription · Dose changes through the patient portal

Starting price

$79$69/month

*Compounded medications are not FDA-approved.

  • Semaglutide $69/mo; tirzepatide $119/mo
  • 5-minute questionnaire; doctor review usually within 24 hours
  • Free 1-2 day shipping: cold-packed, tracked and insured
  • No insurance, no clinic visits, cancel anytime

from $69/month

Visit SiteRead full review
3.8Trustpilot(9,604)

embody prescribes compounded semaglutide at $69/mo and tirzepatide at $119/mo online, ships in 1-2 days, and requires no insurance. Trustpilot: 3.8 from 9,604 reviews.

Read full embody review
2
altRx logo

Exceptional

9.7out of 10

Low-cost GLP-1 care: semaglutide from $89/mo

Clear, flat pricingNo insurance needed

Treatments offered

Compounded semaglutide injection (GLP-1) · Compounded tirzepatide injection (GLP-1 + GIP) · Brand-name Ozempic, Zepbound and Wegovy · Once-weekly injection schedule

Starting price

$199$89/month

*Compounded medications are not FDA-approved.

  • Semaglutide from $89/mo; tirzepatide from $149/mo
  • Brand-name Ozempic, Zepbound and Wegovy available
  • Reviewed by a physician, PA or nurse practitioner
  • Free shipping, arriving in about 5-7 days

from $89/month

altRx sells compounded semaglutide from $89/month and tirzepatide from $149/month at a flat price per dose, plus brand-name Ozempic, Zepbound and Wegovy. Self-pay, no insurance needed.

Read full altRx review

Which GLP-1 drugs are covered by the Medicare Bridge?

According to reporting on the program, the pilot covers:
  • The Wegovy pill and injection (semaglutide)
  • The Zepbound KwikPen (tirzepatide)
  • Foundayo (orforglipron), Eli Lilly's daily pill approved in April 2026
It does not cover Ozempic or Mounjaro prescribed for weight loss (those are the diabetes labels of the same molecules), any compounded version of these drugs (Medicare, like every insurer, does not pay for compounded GLP-1s), or, as far as we can verify, any product outside that list. How the brand drugs differ is covered in Zepbound vs Wegovy vs Ozempic, and the pill-or-injection choice in GLP-1 pills vs injections.

Who is eligible for the $50 Medicare copay?

Eligibility is not automatic. The program applies clinical criteria and requires approval before the $50 copay applies at the counter. Published reporting mentions conditions tied to clinical guidelines and to what happens when the pilot ends, but we have not seen the full rules in a form we can verify, so we do not summarize them. CMS's own program page and your Part D plan are the right sources.
Ask your Part D plan:
  • Am I eligible for the GLP-1 Bridge?
  • Which covered drugs are on your formulary under it?
  • What documentation does my prescriber need to submit for approval?
Ask your prescriber: which of the covered drugs suits me? That choice is based on your medical history, not on price.

Lowest-priced GLP-1 plans

The cheapest published plans, sorted from lowest price, with the terms listed under every price.

What can you do if you don't qualify for the Medicare Bridge?

You use the same cash market as everyone else, which has two tiers.GLP-1 on a $100-$200 budget sorts every option by ongoing price.

Is GLP-1 Treatment Right for You?

GLP-1 medication is prescription-only: a licensed clinician has to decide it is appropriate, and it is not a fit for everyone. Side effects are possible, and they tend to show up in the first few weeks while your body adapts.

Results are usually best when the medication is paired with simple daily habits, such as balanced meals and regular movement.

For both safety and lasting progress, pick a provider that screens you properly before prescribing and keeps following up once treatment starts.

Woman getting a GLP-1 weight loss injection pen ready

How is GLP-1 treatment different for adults over 65?

Two clinical points matter more with age.
  • Muscle and bone. Weight lost on a GLP-1 includes lean mass as well as fat, and protecting muscle and bone matters more as you get older. That argues for resistance exercise and enough protein from day one, and for a clinician who tracks more than the scale.
  • Medication review. People typically take more medications at 65 than at 45, so interactions and existing conditions need a proper review.
GLP-1 weight loss over 40 and exercise on a GLP-1 cover both. For an older adult, a provider offering a real clinician conversation and follow-up is worth more than the lowest row in a price table; our provider-support comparison shows from captured reviews which providers actually respond.

GLP-1s on Medicare: what to do first

If you are on Medicare and considering a GLP-1 for weight, ask your Part D plan about the GLP-1 Bridge before comparing any other prices. $50 a month for a brand-name, FDA-approved drug is the lowest figure on this site for as long as the pilot runs.

If you do not qualify, your cash options are the same as anyone's, and the month 1 vs year one page shows what each truly costs. Program rules and prices change, so everything here is dated and re-verified.

A licensed clinician decides whether treatment is right for you; this page is about paying for it.

Which weight loss provider fits you best?

Our ranking compares the leading providers on price, clinical support and medication choices.

Popular provider matchups

Side-by-side comparisons with checked prices, the ones readers rely on most when choosing.

References and clinical sources

The medication facts on this page rest on FDA guidance and peer-reviewed clinical trials, while prices and plan terms come from what each provider publishes. Use this page as general information, not medical advice, and speak with a licensed clinician before you start any weight loss treatment.

  1. 1.Once-Weekly Semaglutide in Adults with Overweight or Obesity (STEP 1 trial) - New England Journal of Medicine, 2021
  2. 2.Tirzepatide Once Weekly for the Treatment of Obesity (SURMOUNT-1 trial) - New England Journal of Medicine, 2022
  3. 3.FDA Approves New Drug Treatment for Chronic Weight Management (semaglutide / Wegovy) - U.S. Food & Drug Administration, 2021
  4. 4.FDA Approves New Medication for Chronic Weight Management (tirzepatide / Zepbound) - U.S. Food & Drug Administration, 2023
  5. 5.FDA's Concerns with Unapproved GLP-1 Drugs Used for Weight Loss - U.S. Food & Drug Administration
  6. 6.Human Drug Compounding (503A pharmacy standards) - U.S. Food & Drug Administration
  7. 7.Semaglutide Injection - drug information - MedlinePlus, U.S. National Library of Medicine (NIH)